Tapping in Together: A Pilot Study on Group Acupuncture for Ketamine Experience Integration
1 other identifier
interventional
15
1 country
1
Brief Summary
The goal of this pilot trial is to learn about using acupuncture for ketamine experience integration in adults aged 21-65 who are medically cleared for a ketamine prescription. The aim is to inform future controlled trials investigating efficacy by evaluating the success of:
- recruitment
- retention
- assessment procedures
- implementation of group acupuncture interventions performed just after a ketamine experience Participants will be given acupuncture in a group setting after a small-group ketamine experience. The following day, participants will be asked to complete a few brief surveys about their experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2023
CompletedFirst Posted
Study publicly available on registry
October 6, 2023
CompletedStudy Start
First participant enrolled
October 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedJune 27, 2025
June 1, 2025
2 months
September 29, 2023
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Experienced Integration Scale (EIS)
The scale is intended to gain a sense of the status of a participant's integration process after a psychedelic experience. Participants are asked to rate their agreement to 12 statements using a five-point Likert scale with the anchors "strongly disagree," "disagree," "neither agree nor disagree," "agree," and "strongly agree." The items are worded in a positive direction, so that higher scores indicating greater integration.
One day after experience
Experienced Integration Scale (EIS)
The scale is intended to gain a sense of the status of a participant's integration process after a psychedelic experience. Participants are asked to rate their agreement to 12 statements using a five-point Likert scale with the anchors "strongly disagree," "disagree," "neither agree nor disagree," "agree," and "strongly agree." The items are worded in a positive direction, so that higher scores indicating greater integration.
Three months after experience
Study Arms (1)
Treatment Group
EXPERIMENTALThis is the group of participants who will receive group acupuncture after a ketamine experience.
Interventions
The traditional East Asian methods of treating disease by inserting needles along specific pathways or meridians.
Eligibility Criteria
You may qualify if:
- between ages 21-65
- participant in a group ketamine experience between October 1, 2023 and February 28, 2024
You may not qualify if:
- currently pregnant or breastfeeding
- has a terminal illness
- does not pass medical clearance for ketamine prescription
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardea Ketamine Space
New York, New York, 10013, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
William Morris, PhD, DAOM
Academy of Oriental Medicine Austin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Licensed Acupuncturist
Study Record Dates
First Submitted
September 29, 2023
First Posted
October 6, 2023
Study Start
October 9, 2023
Primary Completion
December 1, 2023
Study Completion
March 1, 2024
Last Updated
June 27, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share